The escalating cost of prescription drugs challenges the University to maintain a quality prescription drug benefit within the constraints of finite resources. Like many employers across the country, the University is reexamining its drug benefit plan and investigating strategies to control cost increases that collectively impact the employees and institution. (Excerpt from report).